Woman walking with cane with a caregiver alongside her supporting her

Support & Resources

Financial Support Services

Continuing
Patient support

Hizentra Connect℠ logo

Get the guidance
and support you need

From initial insurance investigation and self-infusion training to just providing someone to talk to, Hizentra Connect, our support program, gathers many resources under one roof.

Our goal is to make it easy to get the guidance and support you need

Medicare

Hizentra is covered under Medicare Part B for CIDP, the same benefit category as IVIg.* To get started, call Hizentra Connect at 1-877-355-4447, Monday-Friday, 8 AM to 8 PM ET.

*100% coverage for those with Medicare Part B and a Medigap plan after Part B annual deductible is met.

Coverage of IVIg when administered in a clinical setting

Copay Support Program

Most eligible people with commercial insurance pay $0 in out‑of‑pocket expenses for Hizentra

Subject to terms and conditions of the Copay Support Program. To read the full terms and conditions, visit here. CSL Behring reserves the right to rescind, revoke, or amend the program at any time without notice.

Free Trial

To help determine if Hizentra is the right therapy for you, see if you are eligible for a 1-month supply of medicine, infusion equipment, and nurse training for free

Support services

When you sign up for Hizentra Connect,
we can always be by your side

Out-of-pocket expenses?

Pay as little as $0!*

*Subject to terms and conditions of the Copay Support Program. To read the full terms and conditions, visit here. CSL Behring reserves the right to rescind, revoke, or amend the program at any time without notice.

Covered for Hizentra?

Good news. 95% of people with insurance (Medicaid, Medicare, private) are covered. Reimbursement Support involves prior authorizations, appeals, and connection to CSL Behring's field reimbursement team who will work with your doctor's office.

Uninsured or underinsured?

Our Patient Assistance Program helps qualified people get the treatment they need.

Insurance lapse?

You may be able to still receive treatment.

Want a free trial?

If you're ready to try Hizentra, you may be able to get a 1-month supply of medicine, infusion equipment, and in-home nurse training for free.

Ask your doctor to submit a free trial referral form

In-home visits with a nurse?

Our In-home nurse support provides a trained nurse to come to your home for up to 4 visits to make sure you’re comfortable self-infusing.

The guidance you need to start on Hizentra

Our Welcome Kit has you covered.

Get Your Kit

Worried about staying on track?

Don't be! The Hizentra App helps you stay the course.

Download app

Want opportunities to connect?

Meet our Patient Advocates.

Sign up

Webinars and live events?

Be our guest!

See upcoming events

Patient advocates are not healthcare professionals or medical experts. For medical questions, please contact your physician. Patient advocates are compensated by CSL Behring LLC. for their time and/or expenses.

Welcome Kits

A strong start
starts here

When you enroll in Hizentra Connect, we'll make sure you get important resources you need in our Welcome Kit, including:

  • Infusion Mat
  • CIDP Patient Brochure
  • Therapy Journal
  • Travel Tips
  • Support Services Brochure
Enroll in Hizentra Connect
Three Hizentra patient advocates feeling confident and happy
Phones featuring the Hizentra app

Hizentra app

Track infusions more easily
with the Hizentra app

The Hizentra app gives you the freedom and flexibility to set treatment reminders and record infusion details right in the palm of your hand.

  • Schedule personalized infusion reminders
  • Scan label(s) and track infusion details
  • Share your infusion history with your PI healthcare provider

Learn more about connecting with other patients

Important Safety Information

WARNING: Thrombosis (blood clots) can occur with immune globulin products, including Hizentra. Risk factors can include: advanced age, prolonged immobilization, a history of blood clotting or hyperviscosity (blood thickness), use of estrogens, installed vascular catheters, and cardiovascular risk factors.

If you are at high risk of blood clots, your doctor will prescribe Hizentra at the minimum dose and infusion rate practicable and will monitor for signs of clotting events and hyperviscosity. Always drink sufficient fluids before infusing Hizentra.

See your doctor for a full explanation, and the full prescribing information for complete boxed warning.

Hizentra®, Immune Globulin Subcutaneous (Human), 20% Liquid, is a prescription medicine used to treat:

  • Primary immune deficiency (PI) in patients 2 years and older
  • Chronic inflammatory demyelinating polyneuropathy (CIDP) in adults

Treatment with Hizentra might not be possible if your doctor determines you have hyperprolinemia (too much proline in the blood), or are IgA-deficient with antibodies to IgA and a history of hypersensitivity. Tell your doctor if you have previously had a severe allergic reaction (including anaphylaxis) to the administration of human immune globulin. Tell your doctor right away or go to the emergency room if you have hives, trouble breathing, wheezing, dizziness, or fainting. These could be signs of a bad allergic reaction.

Inform your doctor of any medications you are taking, as well as any medical conditions you may have had, especially if you have a history of diseases related to the heart or blood vessels, or have been immobile for some time. Inform your physician if you are pregnant or nursing, or plan to become pregnant.

Infuse Hizentra under your skin only; do not inject into a blood vessel.

Self-administer Hizentra only after having been taught to do so by your doctor or other healthcare professional, and having received dosing instructions for treating your condition.

Immediately report to your physician any of the following symptoms, which could be signs of serious adverse reactions to Hizentra:

  • Reduced urination, sudden weight gain, or swelling in your legs (possible signs of a kidney problem).
  • Pain and/or swelling or discoloration of an arm or leg, unexplained shortness of breath, chest pain or discomfort that worsens on deep breathing, unexplained rapid pulse, or numbness/weakness on one side of the body (possible signs of a blood clot).
  • Bad headache with nausea; vomiting; stiff neck; fever; and sensitivity to light (possible signs of meningitis).
  • Brown or red urine; rapid heart rate; yellowing of the skin or eyes; chest pains or breathing trouble; fever over 100°F (possible symptoms of other conditions that require prompt treatment).

Hizentra is made from human blood. The risk of transmission of infectious agents, including viruses and, theoretically, the Creutzfeldt-Jakob disease (CJD) agent and its variant (vCJD), cannot be completely eliminated.

The most common side effects in the clinical trials for Hizentra include redness, swelling, itching, and/or bruising at the infusion site; headache; chest, joint or back pain; diarrhea; tiredness; cough; rash; itching; fever, nausea, and vomiting. These are not the only side effects possible. Tell your doctor about any side effect that bothers you or does not go away.

Before receiving any vaccine, tell immunizing physician if you have had recent therapy with Hizentra, as effectiveness of the vaccine could be compromised.

Please see full prescribing information for Hizentra, including boxed warning and the patient product information.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.

You can also report side effects to CSL Behring's Pharmacovigilance Department at 1-866-915-6958.

View information about Hizentra for:
You are leaving the current website.

The site you are accessing is maintained by a third party over whom CSL Behring has no control. CSL Behring does not review, approve, or necessarily endorse viewpoints, inferences, or conclusions stated in or implied by the content of this site. CSL Behring is not responsible for third-party content or the consequences of your use thereof.

Do you want to continue?